Scientists find a new way to reverse symptoms of Fragile X
Drug compound, tested in mice, could be effective in treating the leading heritable cause of intellectual disability and autism.
Drug compound, tested in mice, could be effective in treating the leading heritable cause of intellectual disability and autism.
Multi-institutional MassCPR initiative announces more than $16.5 million to support 62 Boston-area projects.
Reactivating an enzyme that promotes DNA repair can help to reverse age-related cognitive decline in mice.
The protein Synaptotagmin 7 limits supply of neurotransmitter-containing vesicles for release at synapses.
The Feng lab has developed a next-generation optogenetic system for non-invasive stimulation of neurons.
New CRISPR-based research tool delivers results in an hour; researchers share protocol and kits to advance research and move toward clinical validation.
At MIT, senior Tarun Kamath has explored neuroscience and science policy, while helping his peers find ways to reduce stress.
Picower Institute researchers are embarking on experiments to learn the mechanisms by which coronavirus might affect mental health.
CSAIL's Conduct-A-Bot system uses muscle signals to cue a drone’s movement, enabling more natural human-robot communication.
Prestigious honor society announces more than 250 new members.
Neurologist and researcher Diane Chan pitches in to help New England get through tough times.
Survey from the Saxe Lab aims to measure the toll of social isolation during the Covid-19 pandemic.
MIT professors Sabine Iatridou, Jonathan Gruber, and Rebecca Saxe have been selected to pursue their work “under the freest possible conditions.”
Using magnetic nanoparticles, scientists stimulate the adrenal gland in rodents to control release of hormones linked to stress.
Three MIT undergraduates who use computer science to explore human biology and health honored for their academic achievements.